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A B S T R A C T
The human immune system presents remarkable inter-individual variability in response to pathogens or pertur-
bations. Recent high-throughput technologies have enabled the identification of both heritable and non-heritable
determinants of immune response variation between individuals. In this review, we summarize the advances
made through the Human Functional Genomics Projects (HFGPs), challenges and the need for more refined
strategies. Inter-individual variability in stimulation-induced cytokine responses is influenced in part by age,
gender, seasonality, and gut microbiome. Host genetic regulators especially single nucleotide polymorphisms in
multiple immune gene loci, particularly the TLR1-TLR6-TLR10 locus, have been identified using individuals of
predominantly European descent. However, transferability of such findings to other populations is challenging.
We are beginning to incorporate diverse population cohorts and leverage multi-omics approaches at single cell
level to bridge the current knowledge gap. We believe that such an approach presents the opportunities to
comprehensively assess both genetic and environmental factors driving variation seen in immune response
phenotype and a better understanding of the molecular and biological mechanisms involved.
1. Introduction
The last decade has witnessed a series of cohort-based studies that
emphasized the role of both host and environmental factors such as diet
and lifestyle in determining human phenotypes in health and disease
conditions. It also has become clear that the interaction of host genetics
and environmental factors (among which pathogens causing infections)
is extremely dynamic, cell-type specific, and varies between individuals.
Understanding the impact of these complex interactions on the function
of the cell types in individual-specific manner is crucial to delineate the
molecular basis of variability in phenotypes. However, capturing the
impact of host genetic, pathogen and environmental factors on all the
cellular and biochemical responses that affect phenotypes by any single
omics approach is challenging. To tackle these challenges, we [1] and
others [2] have conceptualized the human functional genomic projects
(HFGPs), in which the main goal is to comprehensively characterize and
understand inter-individual variation of human phenotypes by
combining ‘omics’ technologies and system biology strategies with
in-depth functional phenotyping of the biochemical responses in healthy
and diseased individuals. Although this strategy has been applied to
study several complex diseases in humans, most progress has been made
in immune and infectious diseases. In this review, we would like to
highlight some of the recent and important biological insights gained
from such studies. We also try and identify limitations of the current
strategies and future challenges.
2. Context-dependent regulation of molecular responses
triggered initiation of HFGPs
Most common human diseases such as diabetes, autoimmune dis-
eases, cancer and infectious diseases are complex phenotypes where
multiple genetic and environmental factors are involved. Genome-wide
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association studies (GWAS) have been commonly applied to identify
genetic factors and have been extremely successful in identifying thou-
sands of genetic loci that are significantly associated with hundreds of
such common human diseases [3, 4]. However, pinpointing causal genes
and causal single nucleotide polymorphisms (SNPs) from these loci
remained a bottleneck to obtain further biological insights [5]. To tackle
this challenge, several expression-quantitative trait loci (eQTL) mapping
studies, mainly using blood tissue, were conducted [6]. Although, these
studies helped to establish the link between potential causal genes and
disease SNPs at several loci, for more than 50% of the loci no eQTL genes
were found [7]. Traditionally, these eQTL studies made use of blood cells
from healthy volunteers to identify association between SNPs and gene
expression. However, these studies failed to capture the impact of
interaction between environmental triggers and genetic variation.
We know from many gene expression studies that hundreds to
thousands of genes show differential expression depending on external
stimulation. However, only in the beginning of this decade researchers
started asking the question whether genetic variants also influence the
expression of genes upon stimulation. This led to several stimulation
specific eQTL studies, in which eQTL mappings were performed upon
stimulation of different immune cells with microbial antigens. These
studies not only helped to reveal novel context-specific or response
eQTLs [8, 9, 10], but also suggested that identifying such response eQTLs
can help in identifying disease genes. For example, it was shown that
such response eQTLs toMycobacterium tuberculosiswere more likely to be
genetically associated with the pulmonary TB disease [8]. However,
these studies assessed only RNA levels and did not investigate the
changes in other molecular responses such as inflammatory cytokines or
metabolites.
During the last decade, we studied systemic candidiasis to identify
Candida-specific host defense mechanisms. For this, we performed
comprehensive analysis of transcriptional responses to Candida albicans
and identified type 1 interferon pathway as one of the important
Candida-specific host defence pathways [11]. Interestingly, SNPs in type
I interferon genes affected Candida-induced cytokine production and
were associated with susceptibility to systemic candidiasis. To further
validate this observation, we profiled cytokines produced by peripheral
blood mononuclear cells from 197 individuals of European origin from
the 200 Functional Genomics (200FG) cohort in the Human Functional
Genomics Project [12] in response to Candida and identified SNPs that
affect cytokines levels through cytokine quantitative trait loci (cQTL)
analysis. Interestingly, a cQTL (rs11141235) of Candida-induced IL-6 at
the NAA35-GOLM1 locus was associated with susceptibility to candide-
mia. These studies strongly suggested the causal role of genetic variants
in infectious diseases that affect not only gene expression but also cyto-
kine responses in a context-specific manner. These were some of the
findings from earlier studies together with development in high
throughput ‘omics’ technologies that led to the conceptualization of
HFGPs. In the following sections we will discuss some of the insights
gained by such studies as well as the application of appropriate ‘omics’
technologies.
Until the inception of the HFGPs, there have been no comprehensive
studies in humans to investigate the basis for inter-individual variability
in cytokine responses after stimulation with pathogens. Although results
from this pilot study of 200 Functional Genomics (200FG) cohort from
our group [12] indicated the feasibility of identifying disease relevant
SNPs and genes using this approach, the study itself had several limita-
tions. These were mainly the small sample size, and the availability of
only cytokine data and genetic data. To tackle some of these challenges
the 500 Functional Genomics (500FG) study was initiated.
3. Insights gained from 500 functional genomics project
The 500FG comprises of healthy adults' volunteers recruited from
Western Europe (the Netherlands) whose DNA, microbiome, urine,
serum and plasma samples are available. By profiling comprehensive
molecular, immunological and lifestyle parameters in the 500FG cohort,
we have applied functional genomics approach [13] to understand major
factors that drives inter-individual variability in cytokine response to
several infectious and metabolic triggers.
In the first study within 500FG, we [14] focused on the effect of
environmental and non-genetic host factors (such as age, sex and sea-
sonality) on cytokine production after stimulation with 19 bacterial,
fungal, viral and non-microbial metabolic stimuli. We identified a strong
impact of non-genetic host factors such as age and sex; and additional
novel finding being seasonality effect on cytokine responses. For
example, in examining gender effects, the production of proinflammatory
cytokines released from monocytes was higher in men after stimulation
with diverse stimuli and the role of circulating hormone levels failed to
explain this gender differences. A second study [13] assessed the impact
of genetic variation on cytokine production and elucidated a strong
impact genetic heritability with varying effects on different cytokines in
whole blood, peripheral blood mononuclear cells and macrophages. The
strongest association among the detected 17 (cQTLs) was at the
TLR1-TLR6-TLR10 locus, which was also found to be under strong
evolutionary selection [15]. Strikingly, no genome-wide significant
cQTLs were identified for production of cytokines in macrophages, sug-
gesting that the process of in vitro macrophage differentiation may
neutralize the strong differences in cytokine production between in-
dividuals. Another fascinating observation from this study was that many
cQTLs overlap with loci previously associated with human diseases,
particularly immune-mediated diseases and infectious diseases. Simi-
larly, Aguirre-Gamboa et al. (2016) by investigating environmental and
genetic factors on immune cell populations in peripheral blood and
immunoglobulin levels, identified eight independent genomic loci asso-
ciated with cell count variation and these QTLs overlapped with GWAS
SNPs already known to increase susceptibility to immune-mediated dis-
eases [16].
These findings indicated that performing stimulation studies using
disease relevant antigens or triggers may help understand disease
mechanisms. For e.g. to understand the factors that contribute to het-
erogeneity in the symptoms and outcome of Lyme disease, another study
[17] leveraged functional genomics approach to Borrelia-induced cyto-
kine response in humans. By conducting genetic, transcriptomic, and
functional validation experiments this study revealed an important role
for HIF-1α-mediated glycolysis in regulating the cytokine response to
Borrelia. Furthermore, HIF-1α pathway activation and increase in
glycolysis-derived lactate was also confirmed in Lyme disease patients,
which leads to different symptoms and outcome of Lyme disease. Like-
wise, an extensive GWAS was performed to examine the effect of genetic
variants on candidemia susceptibility [18]. By integrating candidemia
susceptibility SNPs with Candida-induced cQTLs, the researchers
demonstrate that up to 35% of the susceptibility loci influence in vitro
cytokine response upon Candida stimulations, further illustrating how
stimulation studies may facilitate our understanding of disease
pathogenesis.
The role of host microbiome in health and disease is gaining much
needed attention. The impact of gut microbiome on cytokine production
has already been discussed elsewhere [19, 20, 21]. In the context of gut
microbiome, another study from 500FG cohort investigated how differ-
ences in composition and function of gut microbial communities lead to
inter-individual variation in cytokines responsiveness to microbial
stimulations [22]. Here, the researchers measured both monocyte and
lymphocyte-derived cytokines response to three bacteria (LPS, B. fragilis,
and S. aureus) and two fungal (C. albicans conidia and hyphae) stimula-
tions. As a result of the significant inter-individual variation in both
cytokine responses and gut microbial profiles, the researchers performed
correlation analysis between these phenotypes which led to the identi-
fication of three microbiome-cytokine interaction patterns: stimulus
specific (where gut microbial features were correlated with most cyto-
kines, but related to a particular stimulation), cytokine specific (associ-
ations were independent of the type of stimulations), and cytokine and
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stimulus specific patterns (in this case, gut microbial features affected a
particular cytokine response and related to a specific stimulation). The
authors further demonstrated that specific host-microbial interactions
can lead to modulation of specific metabolic pathways, which in turn
may affect the cytokine production. For e.g. in case of TNF-α and IFN-γ
production in response to Candida albicans, it was shown that the levels of
these cytokines were significantly correlated with the microbial meta-
bolic pathways, namely palmitoleic acid metabolism and tryptophan
degradation to tryptophol. Interestingly, these effects were specific to
monocyte derived cytokines but not T-cell derived cytokines. The bio-
logical mechanism responsible for this specificity remain to be
investigated.
Although overall, we observed significant impact of genetics, micro-
biome and non-genetic factors on cytokine responses, it is crucial to tease
apart the proportion of variance explained by each of these factors to the
inter-individual variability in cytokine responses. Therefore, the quan-
titative contribution of immunological and molecular profiles to stimu-
lated cytokine production was systematically assessed [23]. The authors
found that genetic variation (SNPs) explained most of the variance (R2 ¼
0.18), while gut microbiome, immune cell counts, circulating metabo-
lites and seasonality showedmoderate effects (avg.adj R2¼ 0.061, 0.057,
0.041 and 0.041, respectively). Overall, the afore-mentioned studies
pinpoint the enormous advancement made towards our quest to under-
stand the basis of inter-individual differences in cytokine responses upon
stimulation. Although, these studies (summarized in Table 1) focused
mainly on cytokine production, the comprehensive understanding of the
immune landscape variation between individuals requires the consider-
ation of other molecular phenotypes.
4. Application of human functional genomics approaches to
other traits than cytokine responses
Complementary to cytokines, other molecular phenotypes have been
studied to boost our knowledge on the factors contributing to inter-
individual immune response heterogeneity to microbial challenges. For
example, Piasecka et al. (2018) recently examined the impact of age, sex
and genetic factors on the inter-personal differences in transcriptional
response to infection among 1000 individuals of European ancestry
matched for age and sex [24]. The researchers demonstrate that age and
sex influence the expression levels of most immune-related genes. Rela-
tive to sex effects, age effects tend to be more stimulus specific, which
were largely shared across stimulations. Also, eQTL analyses revealed
Table 1. Studies under 500FG investigating determinants of cytokine response variability.
Author (Year) Factor(s) analyzed Main Findings
Ter Horst et al. (2016) Environmental and non-genetic host
factors such as age, sex, BMI, oral
contraceptive, smoking, vitamin D and
seasonality
1. Non-genetic host factors such as age and
sex have strong influence on cytokine
production, with elevated levels of IL-Ra
and IL6- in older individuals
2. Cytokine responses are dependent on
annual seasonality
3. Limited effect of vitamin D on cytokine
production
Li et al. (2016) Host genome/genetic variation 1. Strong impact of heritability on cytokine
response after bacterial, fungal, viral, non-
microbial stimulations.
2. Identification of 17 novel genome-wide
significant cytokine QTLs (cQTLs)
3.cQTLs are enriched for regions under
positive selection
4. Most cQTLs overlap with loci associated
with infectious and autoimmune diseases.
Schirmer et. al (2016) Human gut microbiome (Taxonomic and
functional profiling)
1.Correlating cytokine responses with gut
microbial profiles showed three interaction
patterns: stimulus-specific, cytokine-
specific and cytokine and stimulus specific
associations
2. TNF-α and IFN-γ production are
correlated with metabolic pathways,
specifically palmitoleic acid metabolism
and tryptophan degradation to tryptophol
Oosting et al. (2016) Non-genetic (age, sex, tick bites, smoking,
vitamin D) and genetic factors on Borrelia-
induced cytokine response
1. Age strongly impaired IL-22 responses
but no effect on IL-17 levels
2. HIF-1α-mediated glycolysis plays
important role in regulating cytokine
response to Borrelia.
3. HIF-1α pathway activation and increase
in glycolysis-derived lactate was also
confirmed in Lyme disease patients
4.Two genome-wide significant cQTLs:
rs17615278 and rs11103976 associated
with IFN-γ were identified
Bakker et al. (2018) Host factors (such as age, sex, cell counts,
metabolites, season, platelets, modulators,
hormones and immunoglobins)
Molecular profiles (genome, metabolome,
gut microbiome)
Baseline immunological parameters (IL-
18, IL-18BP, resistin, leptin, adiponectin
and α-1 antitrypsin)
1. Host factors explain up to 67% variation
in cytokine levels
2. Genetics contributes greatly to
interindividual variation (average adjusted
R2 ¼ 0.18) in cytokine response to
pathogens.
3. Individuals with high genetic risk of
(auto)immune disease tend to be high
producers of cytokines in response to
pathogens
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that genetic factors exhibit stronger effect on the expression of limited
number of immune genes than age and sex. Furthermore, most detected
trans-eQTLs had stronger effect upon stimulation, particularly Candida
albicans-specific master regulator at the CRI locus, indicating that most of
the identified trans variants in the CRI (a receptor for C3b and C4b split
products) locus are related to immune response to C. albicans. This
finding pinpoints stimulus-specificity of genetic variants regulatory effect
on immune response.
In addition to transcriptomics and cytokine responses, metabolites
also provide a crucial information to understand disease mechanisms. For
example, in a study to identify specific biological pathways relevant to
tuberculosis meningitis outcome in an Indonesian cohort, van Laarhoven
et al. (2018) applied functional genomics approach, and measured
complete cerebrospinal fluid (CSF) and serum metabolome in HIV-
uninfected tuberculosis meningitis patients and controls [25]. In this
study, CSF tryptophan concentrations were 9-times lower in patients who
survived compared with patients who died. In a second cohort, they
validated these findings and showed that low CSF tryptophan predicted
patient survival. Furthermore, by performing a genetic study to identify
loci predicting CSF tryptophan concentrations, they identified 11 of
tryptophan QTLs. These QTLs predicted survival in a third cohort of
tuberculosis meningitis patients.
In another study, Quach et al. (2016) leveraged RNA sequencing
(RNA-Seq) to characterize the responses of primary monocytes, from
individuals of European and African origin, to diverse Toll-like receptor
(TLR) ligands and influenza A virus subsequent to eQTL mapping. The
researchers identified not only numerous cis-eQTLs contributing to dif-
ferences in immune response both within and between populations, but
most importantly, a strong trans-eQTL hotspot at TRL1 that decreases
expression of proinflammatory genes in Europeans only [26]. This study
reveals that the determinants of differences in host immune responsive-
ness between human populations are largely distinct. Yet, to this end,
most of the studies performed so far under the HFGPs have focused on
individuals of European ancestry especially in the context of cytokines.
However, the immune response to pathogens varies substantially among
populations as multiple factors, such as genetics, epigenetics, (post)
transcriptional and (post)translational regulation, lead to inter-person
and interpopulation variations [27]. Besides, it is well known that ge-
netic architecture of ethnically diverse groups is highly heterogenous due
to population specific variation and variations in allele frequency. The
varying differences in genetic architecture among populations can in-
fluence or can lead to differential effect on people's response to drugs and
its adverse effects. For instance, common variants in CYP2C9, VKORC1,
and CYP4F2 have been reported to account for up to 18%,30%, and 11%
respectively, of the variance in stable warfarin (anticoagulant) dose
among patients of European ancestry but these variants explain less of the
dose variability in patients of other ancestries [28]. For a safer, reliable
and quality medical care for all, functional genomics studies across
diverse populations is indispensable. Table 2 summarizes the content of
the afore-mentioned studies.
5. The need for population-specific human functional genomics
projects
The desire to perform comprehensive functional genomics studies
across diverse populations has in part, strongly motivated by findings of
GWAS. GWAS have led to the discovery of more than 300 susceptibility
loci for autoimmune diseases [29]. Although more than 2800 human
GWAS are recently catalogued, studies that investigated the susceptibil-
ity to infectious diseases or the response to therapies for the treatment
and prevention of infections are just a small fraction of these (4% and
0.66% respectively) [30]. Furthermore, approximately 80% of subjects in
the GWAS catalog, and in most of the studies on the genetic association
with disease were primarily of European descent [31]. The
under-representation of non-European studies impedes our ability to
understand the genetic architecture of human diseases and to predict risk
score of diseases across general population. The poor transferability of
genetic findings from the European studies to African population is ex-
pected as we see clear difference in the genetic architecture between
populations. For example, a study by Magalh~aes et al. (2012), generated
genetic distance map by computing Euclidean genetic distance using
SNPs from 51 worldwide human populations. Findings from this study
further strengthens the need for population specific HFGPs where genetic
similarity analyses show that compared to the European continental
Table 2. Summary of studies under HFGPs interrogating traits variability excluding cytokines.
Author (Year) Factor(s) analyzed Population Main Findings
Piasecka et al. (2018) Age, sex, genetic factors and gene
expression
Healthy European cohort 1. Compared to sex effects, age showed
more stimulus-specific effect on
transcriptional response of most immune-
related
Genes
2. eQTL analyses revealed that genetic
factors had a stronger effect on immune
gene regulation than sex and age
3. Immune response eQTLs are organized
in stimulus-specific manner
Laarhoven et al. (2018) Cerebrospinal fluid (CSF), serum
metabolites and genetics
Indonesian cohort of patients with
Tuberculosis meningitis and controls
1. CSF tryptophan concentrations were 9-
times lower in patients who survived
compared with patients who died.
2. 11 genetic loci predictive for CSF
tryptophan concentrations in tuberculous
meningitis were identified
3. Cerebral tryptophan metabolism is
important for the outcome of tuberculous
meningitis
Quach et al. (2016) Genetics and gene expression Africans and Europeans 1. Cis- and trans-eQTLs contribute to
population difference in immune
responses.
2. Identified trans-eQTL hotspot at TLR1
that decreases expression of pro-
inflammatory genes in Europeans only.
3. Neanderthals introduced variants
affecting immune responses into European
genomes.
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group, the African ethnicities show the greatest diversity. Also, hierar-
chical clustering of the 51 populations showed two main blocks with
distinct separation between African and non-African populations [32].
Below, we will discuss some of the studies that compared the utility of
genetic findings across different populations.
In the context of assessing the transferability of genetic findings to
other populations, a study was conducted to investigate how key genetic
variants implicated in gene expression differ among populations and
subsequent effects on genetic prediction. By performing eQTLmapping in
individuals with African American, Hispanic, and European ancestry, the
researchers demonstrated that the genetic architecture of gene expres-
sion for most predictable genes is sparse [33]. There were genes, for
example TACSTD2 that are well predicted, while others are poorly pre-
dicted across populations. Another interesting insight revealed from this
study is that some genes that are well predicted in one population, pre-
dicted abysmally in other populations, demonstrating the need for
comprehensive genomic studies in diverse population. In the same
context, RNA-seq-based immune response eQTL study to investigate the
transcriptional response to various live bacterial pathogens effects on
African versus European ancestry individuals, reported markedly stron-
ger response to infection induced in macrophages from individuals of
African descent, with inflammatory response genes being more pro-
nounced [34].
Another comparative study of variation in the transcriptional
response of peripheral blood mononuclear cells to bacterial and viral
stimuli between Batwa rainforest hunter-gathers and Bakiga agricultur-
alist from Uganda demonstrate that positive natural selection has
contributed to shaping population differences in immune regulation.
Importantly, across the set of genetic variants driving inter-population
immune response differences, the signatures of positive selection were
disproportionally observed in the rainforest hunter-gathers [35]. These
findings emphasize the relevance of inter-population genetic analysis and
also support the argument for intrapopulation analysis especially in
Africans.
In addition to transcriptional response studies that we discussed
above; many studies also tested the utility of polygenic risk score from
Figure 1. Schematic representation of the need for population-specific human functional immune-genomics projects. Cytokine quantitative trait loci (cQTL) analyses
integrating genome-wide SNPs and induced-cytokine responses identified the TLR locus to be associated with cytokine response in individuals of European
descent only.
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one population to predict the phenotype in another population. For
example, a study by Martin et al. (2017) utilized published summary
statistics to construct polygenic risk scores for eight well-studied phe-
notypes to define the role of demography on polygenic risk prediction
derived from a single-ancestry GWAS. They found that polygenic risk
scores derived from European GWAS are biased when extrapolated to
divergent populations even when the same causal variants are used, with
directional inconsistencies in all scores. For example, despite anthropo-
logical evidence suggesting that West Africans on average are as tall as
Europeans, height was predicted to decrease with genetic distance from
Europeans. Most intriguingly, polygenic risk scores computed for type II
diabetes across populations was observed to vary when summary sta-
tistics are derived from either Europeans-specific or multi-ethnic cohorts
[36].
In addition to genetic background, of course the environmental
challenges such as food habit, climate and pathogens also differ among
these populations. Given the importance gene X environment in-
teractions in determining complex phenotypes, there is a big gap in un-
derstanding the global clinical utility of genetic findings in one specific
population.
To bridge this knowledge gap, the first of the series of HFGPs to be
conducted in non-European populations is beginning to yield interesting
findings. Some genetic variants have been identified to be associated
with induced cytokine responses upon stimulations with pathogens using
European cohort within the HFGPs. Already, interesting genes, pathways
and useful insights have been uncovered from such studies. For example,
a previous study showed that the TLR locus is associated with cytokine
production capacity for many stimulations [13]. Strikingly, a comparable
ongoing study using individuals of African descent failed to identify this
locus to be associated with induced cytokine response (Figure 1). As a
result, it is expected that analyses on genetic variations among diverse
populations will help to identify additional loci, understand further the
mechanisms underlying differential response of the immune system.
6. Future perspectives
Taken together, whilst significant progress has been achieved since
the advent of the HFGPs, it is important to highlight the areas yet to be
explored. To this end, all analyses performed focused primarily on ge-
nomics, metabolomics and added a limited amount of transcriptomics to
validate research findings or prioritize candidate genes. However, to
better understand the basis of varying immune responses in individuals,
these single ‘omics’ approaches will not be sufficient given the
complexity of the biological system. Therefore, future HFGPs seeks to
adopt integrated omics analyses, the current trend to achieve clear
mechanistic insights into the basis for differences in human cytokine
responses among individuals, and the wide range of phenotypic variation
observed across human populations (Figure 2). In this context, few
studies have been performed. Recently, a study using European cohorts
only integrated genomic, metagenomic, metabolic data, immune cell
composition and platelet activation profiles from individuals [23].
Findings by integrating multi-omics layers show that cytokine production
is regulated by both multiple genetic and non-genetic host factors.
Strikingly, they reported that cytokine responses induced by stimulations
could be moderately predicted using multiple baseline profiles. By
leveraging this approach, the authors identified new modulators of
cytokine production. Circulatingmetabolites, amongwhich acetate, were
associated with changes in stimulus-induced cytokine production and
especially in the modulation of TH1 and TH17 responses. Also, volunteers
with increased genetic risk for immune-mediated diseases were more
likely to be high responders in terms of stimulus-induced cytokine
production.
Additionally, applying various omics technologies such as genomics,
proteomics, metabolomics and transcriptomics at single cell level has
become the current routine when investigating cell-to-cell heterogeneity
[37]. Recently, de Vries et al. (2020) integrated genome-wide association
studies with bulk and single cell transcriptomics analyses of immune cells
stimulated with C. albicans to deepen our understanding of anti-Candida
Figure 2. Schematic overview of the concept of human functional immune-genomics projects. The concept aims at recruiting individuals of diverse human pop-
ulations and generating large population-based cohorts. Among other information gathered from the individuals are metadata, stool samples, plasma samples, mi-
crobial samples and DNA for genomics studies. Advanced multi-omics approaches are used to integrate and analyze various datasets with subsequent identification of
biomarkers and therapeutic targets to understand how inter-individual and inter-population immune response variation underlies disease mechanisms. Characterizing
the factors driving immune response variation is critical to the realization of the concept of personalized treatment.
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host response. By leveraging multi-omics technique and cell-type
dependent differential analysis, they show that important cell types
such as monocytes and natural killer (NK) cells are involved in host
response against Candida [38]. These findings provide not only important
insight into disease biology but also serve as a framework for future
studies to extend this analysis with various pathogens in different
populations.
Another important area to tackle is longitudinal genetic studies. The
common approach of investigating the effect of genetic variants at indi-
vidual time points (e.g. SNP at a time) on phenotypic variation has
revealed some important insights. However, this method may not reveal
variants that are affected by epigenetic modifications in different cell
types and tissues over time. The inclusion of repeated measurements
provides additional advantage among others, in understanding the tra-
jectory of traits and disease progression [39]. Therefore, longitudinal
data collection and analyses across diverse populations is imperative to
broaden our knowledge on immune responses to pathogens over time
and to answer questions such as which genetic variants influence
inter-individual variability independent of epigenetic modifications over
time.
7. Conclusion
Even though the advent of the HFGPs had an unprecedented impact
on our knowledge, bringing into light the genetics and non-genetic host
factors contributing to inter-individual heterogeneity in immune re-
sponses, the expansion of such studies to incorporate diverse populations
is needed to realize the personalized medicine in every population. While
most of immunogenetic (e.g. cQTL mappings) and other studies have
been performed in populations of European descent, increasing the
number of studies in non-European populations (using both patient and
population-based cohorts) will make the necessary comparisons between
populations feasible. In addition, this is particularly important consid-
ering the fact that findings from studies using European cohorts within
the HFGPs is not easily transferable, replicating these findings in different
populations will help to pin-point population-specific variants and bridge
the existing disparities in genetic knowledge for non-European pop-
ulations. In addition, the reductionist approach to investigating the basis
of variability in cytokine responses may obscure important insights. In
future HFGPs focused on the immune responses to pathogens, we envi-
sion that integrative approaches to studies of ethnically diverse human
populations will contribute to holistically examine the main and large-
scale interactions of different omics layers to advance our knowledge
and understanding of health and disease.
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